Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

RYBELSUS

NOVO NORDISK CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of RYBELSUS in Canada?

A shortage of RYBELSUS 3MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated June 5, 2026), but it has not started yet.

When will RYBELSUS be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Guide

Ozempic and GLP-1 Shortage in Canada: Current Status

Why Ozempic and other GLP-1 medications have cycled in and out of shortage in Canada, how to check the current status, and what to ask your pharmacist if yours is affected.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Affected strength3MG
Last updated2026-06-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

RYBELSUS

NOVO NORDISK CANADA INC

9MG · DIN 02551039

Different strengthSame dosage formSame routeNo current shortage

WEGOVY

NOVO NORDISK CANADA INC

9.6MG · DIN 02528541

Different strengthDifferent dosage formDifferent routeNo current shortage

PLOSBRIO

NOVO NORDISK CANADA INC

1.34MG · DIN 02568233

Different strengthDifferent dosage formDifferent routeNo current shortage

OZEMPIC

NOVO NORDISK CANADA INC

2.68MG · DIN 02523930

Different strengthDifferent dosage formDifferent routeNo current shortage

SANDOZ SEMAGLUTIDE

SANDOZ CANADA INCORPORATED

1.34MG · DIN 02571501

Different strengthDifferent dosage formDifferent routeNo current shortage

SEVMIA

APOTEX INC

4MG · DIN 02569582

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02497581

Strength

3MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

SEMAGLUTIDE

See all SEMAGLUTIDE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History